Reaction Details Report a problem with these data
Target
Glucagon receptor
Ligand
BDBM50007219
Substrate
n/a
Meas. Tech.
ChEMBL_1338728 (CHEMBL3242199)
IC50
4.0±n/a nM
Citation
 DeMong, D; Dai, X; Hwa, J; Miller, M; Lin, SI; Kang, L; Stamford, A; Greenlee, W; Yu, W; Wong, M; Lavey, B; Kozlowski, J; Zhou, G; Yang, DY; Patel, B; Soriano, A; Zhai, Y; Sondey, C; Zhang, H; Lachowicz, J; Grotz, D; Cox, K; Morrison, R; Andreani, T; Cao, Y; Liang, M; Meng, T; McNamara, P; Wong, J; Bradley, P; Feng, KI; Belani, J; Chen, P; Dai, P; Gauuan, J; Lin, P; Zhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem 57:2601-10 (2014) [PubMed]  Article 
Target
Name:
Glucagon receptor
Synonyms:
GCGR | GL-R | GLR_HUMAN | Glucagon Receptor (GCGR) | Glucagon receptor (GlucR)
Type:
Enzyme
Mol. Mass.:
54026.92
Organism:
Homo sapiens (Human)
Description:
P47871
Residue:
477
Sequence:
MPPCQPQRPLLLLLLLLACQPQVPSAQVMDFLFEKWKLYGDQCHHNLSLLPPPTELVCNRTFDKYSCWPDTPANTTANISCPWYLPWHHKVQHRFVFKRCGPDGQWVRGPRGQPWRDASQCQMDGEEIEVQKEVAKMYSSFQVMYTVGYSLSLGALLLALAILGGLSKLHCTRNAIHANLFASFVLKASSVLVIDGLLRTRYSQKIGDDLSVSTWLSDGAVAGCRVAAVFMQYGIVANYCWLLVEGLYLHNLLGLATLPERSFFSLYLGIGWGAPMLFVVPWAVVKCLFENVQCWTSNDNMGFWWILRFPVFLAILINFFIFVRIVQLLVAKLRARQMHHTDYKFRLAKSTLTLIPLLGVHEVVFAFVTDEHAQGTLRSAKLFFDLFLSSFQGLLVAVLYCFLNKEVQSELRRRWHRWRLGKVLWEERNTSNHRASSSPGHGPPSKELQFGRGGGSQDSSAETPLAGGLPRLAESPF
  
Inhibitor
Name:
BDBM50007219
Synonyms:
CHEMBL3238214
Type:
Small organic molecule
Emp. Form.:
C31H34Cl2F3N7O2
Mol. Mass.:
664.549
SMILES:
CC(C)(C)[C@H]1CC[C@]2(CC1)N=C(C(=O)N2[C@H](CCC(F)(F)F)c1ccc(cc1)C(=O)NCc1nn[nH]n1)c1cc(Cl)cc(Cl)c1 |r,wU:4.3,15.17,wD:7.6,c:11,(50.24,-37.05,;51.42,-38.04,;49.98,-38.57,;51.16,-39.56,;52.86,-37.5,;53.12,-35.99,;54.57,-35.46,;55.76,-36.44,;55.5,-37.96,;54.05,-38.49,;56.17,-34.96,;57.72,-34.9,;58.25,-36.35,;59.73,-36.77,;57.04,-37.3,;57.09,-38.84,;55.77,-39.62,;55.79,-41.16,;54.46,-41.95,;54.48,-43.49,;53.12,-41.19,;53.12,-42.7,;58.42,-39.62,;58.4,-41.17,;59.72,-41.95,;61.07,-41.2,;61.09,-39.66,;59.76,-38.88,;62.39,-41.99,;62.37,-43.53,;63.73,-41.24,;65.05,-42.02,;66.4,-41.27,;67.79,-41.9,;68.84,-40.77,;68.08,-39.43,;66.57,-39.73,;58.49,-33.57,;57.73,-32.24,;58.51,-30.91,;57.74,-29.57,;60.05,-30.91,;60.81,-32.25,;62.35,-32.26,;60.04,-33.59,)|
Structure:
Search PDB for entries with ligand similarity: